Señales en vivo de LIPUM.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 05:15):

Stats
Volumen de hoy	1 375.00
Volumen promedio	17 340.00
Capitalización de mercado	214.24M
EPS	SEK0 ( 2023-10-31 )
Próxima fecha de ganancias	( SEK0 ) 2024-05-09
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.350
ATR14	SEK0.125 (2.17%)

Lipum AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lipum AB (publ) Finanzas

Annual	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK0 (0.00 %)
EPS:	SEK-4.45

FY	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK0 (0.00 %)
EPS:	SEK-4.45

FY	2022
Ingresos:	SEK0
Beneficio Bruto:	SEK-11 000.00 (0.00 %)
EPS:	SEK-6.02

FY	2021
Ingresos:	SEK0.00
Beneficio Bruto:	SEK0.00 (0.00 %)
EPS:	SEK-12.54

Financial Reports:

No articles found.

Lipum AB (publ)

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of pediatric rheumatism and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116. The company was founded in 2010 and is headquartered in Umeå, Sweden.